Condition
Idiopathic Hypersomnia clinical trials and research
As of November 12, 2026, Find a Trial lists 14 Idiopathic Hypersomnia clinical trials that are recruiting, at sites in 14 countries (most in United States (9), France (6), Italy (4)). By phase: Phase 2 (4), Phase 2/3 (2), Phase 3 (2), Phase 4 (1). The most active sponsors are Hospices Civils de Lyon (2), Takeda (2). There are also 2 NIH-funded research projects on Idiopathic Hypersomnia, with $1.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 2NIH research projects
- 14Countries
Newest Idiopathic Hypersomnia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Long-term test of TAK-360 in people with narcolepsy or idiopathic hypersomnia | Phase 2/3 | Chula Vista, California and 32 other locations | Recruiting | Jun 15, 2026 |
| Expanded-dosing Xywav vs placebo in narcolepsy and IH | Phase 3 | Birmingham, Alabama and 14 other locations | Recruiting | Jun 4, 2026 |
| Phase 3 HBS-301 for idiopathic hypersomnia | Phase 3 | Birmingham, Alabama and 41 other locations | Recruiting | Mar 30, 2026 |
| Long-term ORX750 treatment for people with narcolepsy or idiopathic hypersomnia | Phase 2 | Auburn, Alabama and 23 other locations | Recruiting | Jul 31, 2025 |
| Diet changes to reduce sleepiness in narcolepsy and idiopathic hypersomnia | — | Macquarie Park, New South Wales | Recruiting | Jun 5, 2025 |
| Evaluating TAK-360 for daytime sleepiness in adults with Idiopathic Hypersomnia | Phase 2 | Redwood City, California and 28 other locations | Recruiting | Feb 6, 2025 |
| Long-term treatment with ALKS 2680 for narcolepsy and idiopathic hypersomnia | Phase 2/3 | Cullman, Alabama and 49 other locations | Recruiting | Jan 10, 2025 |
| Testing ORX750 for Narcolepsy and Idiopathic Hypersomnia | Phase 2 | Auburn, Alabama and 36 other locations | Recruiting | Dec 31, 2024 |
| Understanding how food intake affects sleep in narcolepsy and hypersomnia patients | — | Clermont-Ferrand and 1 other locations | Recruiting | Jul 3, 2024 |
| Exploring mind-wandering and its effects in narcolepsy and hypersomnolence | — | Lyon | Recruiting | Jun 13, 2024 |
All recruiting trials (14)
-
Long-term test of TAK-360 in people with narcolepsy or idiopathic hypersomnia
This study tests TAK-360 over an extended period to see if it is tolerable for people with narcolepsy type 1, narcolepsy type 2, or idiopathic hypersomnia who completed an earlier TAK-360 trial.
-
Expanded-dosing Xywav vs placebo in narcolepsy and IH
This study tests whether expanded nightly dosing of Xywav helps adults with narcolepsy or idiopathic hypersomnia, compared with placebo.
-
Phase 3 HBS-301 for idiopathic hypersomnia
This trial will test whether the oral medicine HBS-301 helps adults with idiopathic hypersomnia reduce daytime sleepiness, sleep inertia, and fatigue.
-
Long-term ORX750 treatment for people with narcolepsy or idiopathic hypersomnia
This open-label extension will try continued ORX750 treatment in people with narcolepsy or idiopathic hypersomnia who completed the earlier ORX750 parent study.
-
Diet changes to reduce sleepiness in narcolepsy and idiopathic hypersomnia
This project will try whether a 12-week whole-food ketogenic diet versus an isocaloric standard whole-food diet reduces daytime sleepiness and improves quality of life in adults with narcolepsy or idiopathic hypersomnia.
-
Evaluating TAK-360 for daytime sleepiness in adults with Idiopathic Hypersomnia
This study is testing a new medication called TAK-360 to see if it can help adults with Idiopathic Hypersomnia feel less sleepy during the day.
-
Long-term treatment with ALKS 2680 for narcolepsy and idiopathic hypersomnia
This study is testing how well a new medication called ALKS 2680 works for people with narcolepsy or idiopathic hypersomnia over a long period of time.
-
Testing ORX750 for Narcolepsy and Idiopathic Hypersomnia
This study is testing a new medication called ORX750 to see if it can help people with narcolepsy or idiopathic hypersomnia feel more awake and improve their daily lives.
-
Understanding how food intake affects sleep in narcolepsy and hypersomnia patients
This study is testing how what people eat affects their sleep and daytime sleepiness in patients with narcolepsy and hypersomnia to find better ways to manage their health.
-
Exploring mind-wandering and its effects in narcolepsy and hypersomnolence
This study is testing how daydreaming affects thinking and creativity in people with narcolepsy and excessive sleepiness.
-
Evening melatonin plus morning bright light for idiopathic hypersomnia
This trial will test whether taking melatonin at night and using bright light in the morning reduces daytime sleepiness and long sleep times in adults with idiopathic hypersomnia.
-
Using low sodium oxybate to improve sleep in patients with idiopathic hypersomnia
This study is testing if low sodium oxybate can help people with idiopathic hypersomnia sleep better and stay asleep longer.
-
Registry of patients with sleep disorders
This study is collecting information from people with sleep disorders to see how these conditions affect their lives and to track their progress over time.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Nocturnal Sleep Signature for Diagnosing Idiopathic Hypersomnia
A study to develop an objective sleep-based biomarker to diagnose idiopathic hypersomnia in adolescents.
-
Creating a new way to diagnose idiopathic hypersomnia using sleep patterns
This study is looking to find a new way to diagnose idiopathic hypersomnia, a condition that makes you feel really sleepy during the day, by identifying specific biological markers in your sleep patterns, so that people can get the right help more easily.
Related topics
Quick answers
How many Idiopathic Hypersomnia clinical trials are recruiting right now?
14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (9 trials), France (6 trials), Italy (4 trials), Spain (4 trials), Canada (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 2/3: 2, Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.